Benzinga | Jan 28, 2022 07:26AM EST

Rosenblatt Maintains Buy on Teradyne, Lowers Price Target to $165

Rosenblatt analyst Kevin Garrigan maintains Teradyne (NASDAQ:TER) with a Buy and lowers the price target from $180 to $165.